CSL, plas­ma com­pa­nies win re­ver­sal on suit over Bor­der Pa­trol block­ade of visas for paid col­lec­tions

Last June, US Cus­toms and Bor­der Pro­tec­tion told Mex­i­cans seek­ing to sell their blood plas­ma at bor­der sites run by com­pa­nies such as CSL that they could no longer en­ter the US with “B‑1” busi­ness vis­i­tor visas.

The de­ci­sion de­liv­ered a blow to the com­pa­nies run­ning the sites, which un­til then, re­lied on the Mex­i­can donors to cross in­to the US and sell plas­ma at dozens of bor­der fa­cil­i­ties in ex­change for about $50 per do­na­tion. Com­pa­nies such as CSL and Gri­fols, which sued CBP, es­ti­mate that their cross-bor­der do­na­tions are re­spon­si­ble for about 5-10% of all US plas­ma col­lec­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER